Prophylactic vaccine antigen

Prophylactic vaccine antigens represent a broad category of exogenous substances, typically derived from pathogens such as viruses, bacteria, or parasites, designed to stimulate a protective immune response in a host. Unlike traditional therapeutic targets which are endogenous host proteins like receptors or enzymes, these antigens are introduced into the body to train the immune system to recognize and neutralize specific infectious agents before a natural infection occurs (World Health Organization, 2023). Upon administration, these antigens are processed by professional antigen-presenting cells and presented to T-cells and B-cells, leading to the production of specific antibodies and the establishment of long-term immunological memory (CDC, 2021). This category encompasses a wide range of molecular types, including inactivated toxins (toxoids), recombinant proteins, polysaccharides, and nucleic acids (mRNA or DNA) that encode the antigen. The primary clinical application is the prevention of infectious diseases, and the specific molecular target is the pathogen itself rather than a discrete host molecule (ChEMBL, 2024).

Other names

Vaccine antigensImmunogensExogenous antigensPathogen-derived antigensProtective antigens

Induction of active acquired immunity through the stimulation of B-lymphocytes and T-lymphocytes against specific pathogen-derived epitopes.